Elamin H Elbasha (Elamin Elbasha)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Topics

Decision Making

Radical Prostatectomy

Sentinel Lymph Node

Top Venues

Infectious diseases and therapy

PharmacoEconomics

This page only lists publications with an associated author ORCID identifier.

Publications

Ibrahim Diakite, Bruno Martins, Kwame Owusu-Edusei, Palmer Cody, Oscar Patterson-Lomba, Andres Gomez-Lievano, Abigail Zion, Ryan B Simpson, Vincent J Daniels, Elamin H Elbasha
Structured Literature Review to Identify Human Papillomavirus's Natural History Parameters for Dynamic Population Models of Vaccine Impacts. Infectious diseases and therapy 13 (5) (2024)
Ibrahim Diakite, Bruno Martins, Kwame Owusu-Edusei, Palmer Cody, Oscar Patterson-Lomba, Andres Gomez-Lievano, Abigail Zion, Ryan B Simpson, Vincent J Daniels, Elamin H Elbasha
Structured Literature Review to Identify Human Papillomavirus's Natural History Parameters for Dynamic Population Models of Vaccine Impacts. Infectious diseases and therapy (2024)
Ibrahim Diakite, Bruno Martins, Kwame Owusu-Edusei, Palmer Cody, Oscar Patterson-Lomba, Andres Gomez-Lievano, Abigail Zion, Ryan B Simpson, Vincent J Daniels, Elamin H Elbasha
Structured Literature Review to Identify Human Papillomavirus's Natural History Parameters for Dynamic Population Models of Vaccine Impacts. Infectious diseases and therapy 13 (5) (2024)
Ibrahim Diakite, Bruno Martins, Kwame Owusu-Edusei, Palmer Cody, Oscar Patterson-Lomba, Andres Gomez-Lievano, Abigail Zion, Ryan B Simpson, Vincent J Daniels, Elamin H Elbasha
Structured Literature Review to Identify Human Papillomavirus's Natural History Parameters for Dynamic Population Models of Vaccine Impacts. Infectious diseases and therapy 13 (5) (2024)
Min Huang, Tianyan Hu, Jessica Weaver, Kwame Owusu-Edusei, Elamin H Elbasha
Cost-Effectiveness Analysis of Routine Use of 15-Valent Pneumococcal Conjugate Vaccine in the US Pediatric Population. Vaccines 11 (1) (2023)
Min Huang, Tianyan Hu, Jessica Weaver, Kwame Owusu-Edusei, Elamin H Elbasha
Cost-Effectiveness Analysis of Routine Use of 15-Valent Pneumococcal Conjugate Vaccine in the US Pediatric Population. Vaccines 11 (1) (2023)
Min Huang, Tianyan Hu, Jessica Weaver, Kwame Owusu-Edusei, Elamin H Elbasha
Cost-Effectiveness Analysis of Routine Use of 15-Valent Pneumococcal Conjugate Vaccine in the US Pediatric Population. Vaccines 11 (1) (2023)
Elamin H Elbasha
Authors' Reply to Comment on "Risk-Adjusted Performance Measures". PharmacoEconomics 40 (7) (2022)
Oluwaseun Sharomi, Ilaria Xausa, Robert Nachbar, Matthew Pillsbury, Ian Matthews, Tanaz Petigara, Elamin H Elbasha, Manjiri Pawaskar
Modeling the Impact of Exogenous Boosting and Universal Varicella Vaccination on the Clinical and Economic Burden of Varicella and Herpes Zoster in a Dynamic Population for England and Wales. Vaccines 10 (9) (2022)
Elamin H Elbasha
Cost‑Effectiveness Risk‑Aversion Curves: Comparison of Risk-Adjusted Performance Measures and Expected-Utility Approaches. PharmacoEconomics 40 (5) (2022)
Erik J Dasbach, Elamin H Elbasha
Verification of Decision-Analytic Models for Health Economic Evaluations: An Overview. PharmacoEconomics 35 (7) (2018)